ACT

DEC. 10/2015

Advertisment

news roundup

ICON Acquires PMG Research

The acquisition of PMG Research is intended to enhance ICON’s ability to access and engage with investigator sites and patients through its network of 48 physician practices and large multi-specialty healthcare institutions throughout North Carolina, South Carolina, Tennessee and Illinois.


Phase II Oncology Trial Uses EORTC Screening

EORTC's Screening Patients for Efficient Clinical Trial Access (SPECTA) is a pan-European clinical trial site and cancer patient molecular screening network established by EORTC in collaboration with more than 30 leading cancer treatment centers in 11 European countries

WIRB-Copernicus Launches Non-Profit Foundation

One goal of the WCG Foundation is to make IRB review more affordable for patients who are desperate to gain access to experimental treatments.


Quintiles Contributes to Apple's ResearchKit

Quintiles' contribution to ResearchKit should enable the apps it produces with the framework to further engage patients participating in clinical research.

In this edition

ICON Acquires PMG Research
Engaging Physicians, Staff and Patients in Oncology Trials
What Does the Engaged Patient Look Like?

Events

Expanded Access Programs 2016

Advertisment

articles

Engaging Physicians, Staff and Patients in Oncology Trials

Accruing patients depends greatly on engaged, enthusiastic PIs, as they are the gatekeepers in helping patients decide to participate in clinical trials.

advertisment

blogs

What Does the Engaged Patient Look Like?

A lack of analytics and measurement metrics for patient engagement is needed to help measure success of patient centric initiatives.

Advertisment

 


Advertisment

Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
[email protected]

Advertise

Russ Pratt
Publisher
[email protected]